載入...
First-in-child use of the oral soluble guanylate cyclase stimulator riociguat in pulmonary arterial hypertension
Riociguat has been approved for use in adults with pulmonary arterial hypertension (PAH) or chronic thromboembolic pulmonary hypertension. No clinical data on its therapeutic use in children with PAH are currently available. We report the case of a now four-year-old boy who initially presented at th...
Na minha lista:
| 發表在: | Pulm Circ |
|---|---|
| Main Authors: | , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
SAGE Publications
2017
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5731721/ https://ncbi.nlm.nih.gov/pubmed/29099661 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045893217743123 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|